SEC Form 4 reporting owner

Turtle Cameron

Turtle Cameron has filed 34 Form 4 transactions reported between December 1, 2025 and September 1, 2026, as Chief Executive Officer of Spyre Therapeutics, Inc. and a reporting owner of Damora Therapeutics, Inc..

Name as filed: Turtle Cameron

Open-market buys, 24 mo

None

reported

Open-market sales, 24 mo

$8.9M

32 lines

Companies

with Form 4 filings

Latest transaction

Sep 1, 2026

transaction date

Roles and reported holdings

SYRESpyre Therapeutics, Inc.
Dec 1, 2025 – Sep 1, 2026
Chief Executive Officer
Held directly552,540 sh as of Sep 1, 2026 · Form 4
24 months: $8.9M sold
DMRADamora Therapeutics, Inc.
Mar 23, 2026
Reporting owner
No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 34 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

Date	Company	Type	Shares	Price	Value	Owned after	Filing
Sep 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	400	$89.07	$36K@ $89.07	552,540	Form 4
Sep 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	3,700	$88.06	$326K@ $88.06	552,940	Form 4
Sep 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	8,400	$87.15	$732K@ $87.15	556,640	Form 4
Sep 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	2,500	$86.36	$216K@ $86.36	565,040	Form 4
Aug 3, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	16	$97.46	$2K@ $97.46	567,540	Form 4
Aug 3, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	1,392	$96.82	$135K@ $96.82	567,556	Form 4
Aug 3, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	5,635	$95.93	$541K@ $95.93	568,948	Form 4
Aug 3, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	7,157	$95.10	$681K@ $95.10	574,583	Form 4
Aug 3, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	800	$93.97	$75K@ $93.97	581,740	Form 4
Jul 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	590	$88.91	$52K@ $88.91	582,540	Form 4
Jul 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	4,234	$88.12	$373K@ $88.12	583,130	Form 4
Jul 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	10,176	$87.44	$890K@ $87.44	587,364	Form 4
Jun 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	3,294	$71.38	$235K@ $71.38	597,540	Form 4
Jun 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	8,149	$70.50	$575K@ $70.50	600,834	Form 4
Jun 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	3,557	$69.40	$247K@ $69.40	608,983	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	300	$74.96	$22K@ $74.96	612,540	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	1,700	$74.23	$126K@ $74.23	612,840	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	3,100	$73.14	$227K@ $73.14	614,540	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	1,000	$71.76	$72K@ $71.76	617,640	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	3,600	$70.77	$255K@ $70.77	618,640	Form 4
May 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	5,300	$69.54	$369K@ $69.54	622,240	Form 4
Apr 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	2,656	$49.92	$133K@ $49.92	627,540	Form 4
Apr 1, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	12,344	$49.20	$607K@ $49.20	630,196	Form 4
Mar 23, 2026	DMRA	Grant or awardCode A · direct	37,313	—	—	37,313	Form 4
Mar 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	9,100	$42.49	$387K@ $42.49	642,540	Form 4
Mar 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	5,900	$41.73	$246K@ $41.73	651,640	Form 4
Feb 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	14,043	$32.87	$462K@ $32.87	657,540	Form 4
Feb 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	957	$31.82	$30K@ $31.82	671,583	Form 4
Jan 9, 2026	SYREChief Executive Officer	Grant or awardCode A · direct	528,000	—	—	528,000	Form 4
Jan 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	100	$32.39	$3K@ $32.39	671,907	Form 4
Jan 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	2,191	$31.79	$70K@ $31.79	672,007	Form 4
Jan 2, 2026	SYREChief Executive Officer	Open-market saleCode S · direct	12,709	$30.47	$387K@ $30.47	674,198	Form 4
Dec 1, 2025	SYREChief Executive Officer	Open-market saleCode S · direct	4,005	$29.83	$119K@ $29.83	686,907	Form 4
Dec 1, 2025	SYREChief Executive Officer	Open-market saleCode S · direct	10,995	$28.73	$316K@ $28.73	690,912	Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.